Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma January 11, 2018 Type of Cancer Genito-Urinary Sponsor Hoosier Protocol Number CRN GU16-260 To Learn More Call 201-510-0910